Company Overview

NEXGEL, Inc. is a U.S.-based specialty medical technology and consumer healthcare company focused on the development and commercialization of high-water-content hydrogel products. The company operates at the intersection of the medical device, wound care, and consumer health and beauty industries. Its core competency is proprietary hydrogel technology designed to deliver moisture, cooling, absorption, and therapeutic support across a range of applications.

The company generates revenue through the sale of branded and private-label hydrogel-based products, primarily in wound care dressings, medical consumables, and over-the-counter consumer solutions. NEXGEL, Inc. evolved from earlier hydrogel manufacturing operations and became publicly traded in 2021 following a spin-off and recapitalization, positioning itself as a focused pure-play hydrogel platform company serving both medical and consumer markets.

Business Operations

NEXGEL, Inc. operates through a single integrated business model centered on the development, manufacturing, and commercialization of hydrogel products. Its primary business lines include medical hydrogel products, such as wound care dressings and medical consumables, and consumer hydrogel products, including pain relief patches, scar treatments, and beauty-related applications. Revenue is generated through direct product sales, private-label manufacturing, and distribution partnerships.

The company maintains in-house manufacturing capabilities in the United States, controlling key aspects of formulation, production, and quality assurance for its hydrogels. Operations are primarily domestic, with international sales conducted through distributors and commercial partners. The company has historically worked with third-party brands and healthcare suppliers rather than relying on large-scale direct-to-consumer infrastructure.

Strategic Position & Investments

The strategic direction of NEXGEL, Inc. emphasizes expanding commercialization of its hydrogel platform across higher-margin medical and branded consumer products. Growth initiatives include launching new proprietary products, increasing private-label manufacturing relationships, and expanding penetration in wound care and dermatological applications. The company has also focused on optimizing manufacturing efficiency to support scalability.

Investment activity has centered on internal product development rather than large-scale acquisitions. NEXGEL, Inc. leverages its hydrogel intellectual property and formulation expertise to enter adjacent use cases, including advanced wound care and skin health. Public disclosures indicate no material acquisitions or controlling investments in unrelated businesses as of the most recent reporting periods.

Geographic Footprint

NEXGEL, Inc. is headquartered in the United States and conducts the majority of its manufacturing and operational activities domestically. Its primary customer base is concentrated in North America, particularly within U.S. medical supply, healthcare, and consumer product channels.

International exposure is achieved through distributors and commercial partners serving select markets in Europe, Asia, and other regions, though international sales represent a smaller portion of total revenue compared to domestic operations. The company does not report significant foreign manufacturing facilities or region-specific subsidiaries based on available public disclosures.

Leadership & Governance

NEXGEL, Inc. is led by an executive team with experience in medical products, operations, and corporate finance. Leadership emphasizes disciplined capital allocation, product commercialization, and leveraging proprietary technology to drive sustainable revenue growth. The board and management team oversee governance consistent with U.S. public company standards.

Key executives include:

• Adam R. Levy – President & Chief Executive Officer
• Matthew T. Troup – Chief Financial Officer
• Mark A. Feig – Chief Operating Officer
• Richard A. Harrison – Chairman of the Board

The leadership team’s strategic vision centers on establishing NEXGEL, Inc. as a leading specialized hydrogel platform company within medical and consumer health markets while maintaining operational focus and regulatory compliance.